KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium

Similar documents
AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

Steal Syndrome: The Role of the Vascular Lab

Vascular Access creation in the US A surgical perspective. Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next

Sonographic Evaluation of an Immature Brescia-Cimino Fistula

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Selection of Permanent Hemodialysis Vascular Access

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS

Hemodialysis Fistula Maturation Consortium

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Jimmy Wei Hwa Tan, Surg, MD

Disclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest

Supera for the Juxta-anastomotic AVF Stenosis

First experience with DCB for treatment of dialysis access stenosis The Greek experience


Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

LUTONIX AV Clinical Trial

Doppler Ultrasound: is it a third generation AVF surveillance method?

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Preservation of Veins and Timing for Vascular Access

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Lutonix in AV fistula and Early look AV IDE trial data

Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?

Disclosure Statement. Objectives. Novel Therapies for Vascular Access Dysfunction: OptiflowDevice, Gene Therapy, and Sirolimus Wrap 2/29/2012

ASDIN 7th Annual Scientific Meeting

Pitfalls in pushing fistulas ----

AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE

HTA ET DIALYSE DR ALAIN GUERIN

A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation

Distal Hypoperfusion Ischemic Syndrome (DHIS)

Evaluation of AVF and AVG

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System

Regardless of whether you are a vascular surgeon,

HD Scanning: Velocities and Volume Flow

Vascular Access for Haemodialysis. Mike Stephens

Imaging Strategy For Claudication

PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S

Evaluation of hemodialysis arteriovenous fistula before and after surgery: Teaching points

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty

Superficialización de la vena basílica. Pierre BOURQUELOT, Paris

Medical Director/Surgeon as Partners WebEx February 11, 2010

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC

UC SF. Disclosures. Vascular Assessment of the Diabetic Foot. What are the best predictors of wound healing? None. Non-Invasive Vascular Studies

Vascular Access Options for Apheresis Medicine

JMSCR Vol 04 Issue 11 Page November 2016

Vascular Access Study Overview and Implementation

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

Introduction. Introduction 2/18/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life

Goals. Access flow and renal artery stenosis evaluation by Doppler ultrasound. Reimbursement. WHY use of Doppler Ultrasound

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV

IN ARTERIOVENOUS FISTULA FAILURE

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?

Incident Hemodialysis

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access

Tale of Neglected Aneurysm

Int J Adv Med. For your questions please send message to

COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Department of Vascular Surgery, Maastricht University, Maastricht - The Netherlands 2

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

Upper Extremity Venous Duplex. Michigan Sonographers Society Fall Ultrasound Symposium October 15, 2016

Cannulation Techniques Webinar

Arterial Pressure in CKD5 - ESRD Population Gérard M. London

Il paziente anziano, evidenza e survey nazionale

Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients

Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography

ASDIN 8th Annual Scientific Meeting

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

4/30/2014. In Vitro Study of AVF Outflow Vein Wall Shear Stress and Pulse Pressure

Utopia Health Career Center, LLC. Do not distribute without permission.

mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).

THE HEMODYNAMICAL EFFECTS OF ARTERIOVENOUS FISTULA VERDIEPEND INDIVIDUEEL PROJECT-MEDICAL ENGINEERING INTRODUCTION... 2

The Gold Standard. ASDIN 2014 Scientific Meeting. When is an AVF mature? Longitudinal Assessment of AVF Maturation with Ultrasound.

For exam: VL DUPLEX EXTREMITY VEINS UNILAT LT

Fistula/Graft Protection. Leslie Dork Renal Medicine Associates

Disclosures. Carotid artery stenting. Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence

Doppler ultrasound role in the evolution and evaluation of the complications of vascular hemodyalisis access.

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Arteriovenous Graft Modeling and Hemodynamic Interpretation

MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai

VFI Technology to Change the Way You Work

Chapter 2 Proximal Forearm Arteriovenous Fistula Creation

Preoperative Venous Intimal Hyperplasia, Postoperative Arteriovenous Fistula Stenosis, and Clinical Fistula Outcomes

Access blood flow in mature arteriovenous fistulas is related to the risk of secondary failure

Case Endovascular management of non maturing dyalisis vascular access

PEER MENTORSHIP TRAINING PROGRAM ESRD National Coordinating Center (NCC)

Lutonix AV Clinical Trial

Transcription:

DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters for dialysis access Goal for fistula prevalence is 65% Ideally, AVF is created prior to the initiation of dialysis (when egfr <30 ml/min/1.73m 2 ) and the patient will have functional permanent access at the initiation of dialysis Overview Definition of a mature fistula Using technical factors to predict maturation Using patient characteristics to predict maturation Future directions Am J Kidney Dis 2006 1

Adequate fistulas and dialysis Robbins et al. >500ml/min and >4mm had 95% likelihood of success vs 33% if both negative Society Guidelines (expert recommendations) KDOQI: 600ml/min blood flow, 6mm diameter & 6mm deep within 6 weeks of surgery SVS: 500ml/min & 5mm at 4-6 weeks European Best Practice: 600ml/min & 5mm at 4 weeks For most patients, an AVF with 400ml/min blood flow and 4mm diameter will be sufficient Radiology 2002; Am J Kidney Dis 2006; JVS 2008; NDT 2007 Who gets a non-maturing fistula? 1. Patients over 65 years old 2. A patient without vein mapping 3. The patient with a fistula created by an intern 4. Patients with arteries and veins that do not remodel 8% 23% 4% 65% 1 2 3 4 What technical factors are important? Preoperative ultrasound mapping Vein diameter, patency and compressibility Arterial diameter and wall characteristics Operative factors Intraoperative blood flow Surgeon experience Systematic review of risk factors for fistula non-maturation Radial artery diameter <2mm Cephalic vein diameter <2mm Intraoperative blood flow <170ml/min (radial) or <280ml/min (brachial) Relative risk of nonmaturation (95% CI) Estimated Sensitivity Estimated Specificity 1.5 (0.9 to 2.5) 38% 72% 1.9 (1.5 to 2.3) 38% 91% 3.5 (2.6 to 4.8) 50% 87% Standards for minimum vessel size and minimum intraoperative blood flow have moderate specificity for fistula non-maturation, but poor sensitivity Voormolen et al. JVS 2009 2

What about patient factors? Traditional cardiovascular risk factors Age Race Gender Diabetes Known CAD or PAD Who needs an AVF? In 2008, 110,000 patients were diagnosed with ESRD Median age 64.9 years About 60% men, 40% women White 65%, African-American 29% Cause of ESRD: Diabetes mellitus 45% Hypertension 30% Voormolen et al. JVS 2009 USRDS ADR 2010 Incidence of ESRD in the US Traditional risk factors and maturation USRDS ADR 2010 Lok et al, JASN 2006 3

Predicting maturation today Intraoperative blood flow is the single best method for detecting a fistula at high risk for nonmaturation Preoperative vein and arterial mapping with duplex ultrasound using size criteria (cephalic vein <2mm, radial artery <2mm) can predict non-maturation Patient characteristics add little to predicting fistula maturation Maturation is a physiologic process 400ml/min 10ml/min 450ml/min 4-6 weeks 50ml/min 50ml/min Vascular physiology as a predictor of maturation EFAVF Study Looking for better phenotype of the AVF patient to develop better predictors which fistula will mature and what therapies might improve the maturation process Endothelium/flow mediated vasodilation (FMD) Arterial elasticity (pulse wave velocity) MRI/MRA characterization of AVF blood flow (volume, velocity, shear stress) and structure (diameter, geometry, wall thickness) Gene expression Serum inflammatory biomarkers AVF Maturation 4

AVF Hemodynamics Characterizing anatomy and flow after AVF creation with MRA V-HEALTH Study Extra-vascular allogeneic endothelial cells to improve AVF or AVG outcomes Subset analysis 31 AVF patients: Diabetics had significantly less vein dilation at 24 weeks (-0.6mm vs 2.3mm, p<0.005) Diabetics treated with EC matrix gel had more vein dilation at 24 weeks (+0.6mm vs -1.7mm, p=0.06) Conte, CJASN 2011, In Press Conclusions Patients needing AVF are older and have a high prevalence of cardiovascular co-morbidities AVF maturation is a dynamic physiologic process that involves remodeling of both the artery and vein Traditional cardiovascular risk factors poorly predict maturation Technical factor such as minimum vein and artery diameters and intraoperative blood flow are currently the best predictors of non-maturation Endothelial physiology is an attractive target for describing, predicting and eventually affecting fistula maturation 5

Thank you 6